AZN
AstraZeneca PLCNASDAQHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$314.44B
P/E Ratio
31.06
EPS
$6.53
Beta
0.28
52W High
$210.50
52W Low
$120.37
50-Day MA
$195.11
200-Day MA
$172.01
Dividend Yield
1.57%
Profit Margin
17.40%
Forward P/E
19.53
PEG Ratio
1.67
About AstraZeneca PLC
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide. The company is headquartered in Cambridge, the United Kingdom.
Fundamentals
| Revenue (TTM) | $58.74B |
| Gross Profit (TTM) | $47.99B |
| EBITDA | $19.28B |
| Operating Margin | 21.60% |
| Return on Equity | 22.80% |
| Return on Assets | 8.19% |
| Revenue/Share (TTM) | $37.90 |
| Book Value | $31.38 |
| Price-to-Book | 6.18 |
| Price-to-Sales (TTM) | 5.35 |
| EV/Revenue | 5.78 |
| EV/EBITDA | 17.40 |
| Quarterly Earnings Growth (YoY) | 53.90% |
| Quarterly Revenue Growth (YoY) | 4.10% |
| Shares Outstanding | $1.55B |
| Float | $1.54B |
| % Insiders | 0.04% |
| % Institutions | 57.09% |
Analyst Ratings
Consensus ($209.89 target)
2
Strong Buy6
Buy1
HoldData last updated: 4/7/2026